News

MEET: Ali Ghaidan, CEO and Founder of RMDM

MEET: Ali Ghaidan, CEO and Founder of RMDM

This week healthcare copywriter, Dee Primett, interviews RMDM’s CEO and Founder, Ali Ghaidan.   In this interview, Ali shares more about his background, the story behind RMDM, PanTum Detect and his visions for the future of the company.  RMDM is a one-stop shop for...

COVID-19 Hits Breast Cancer Screenings

COVID-19 Hits Breast Cancer Screenings

Breast cancer is the most common cancer in the UK, with around 12,000 women diagnosed with the condition every year. Unfortunately, this week an analysis of NHS England figures by Cancer Research UK has found that around 10,600 fewer women started treatment for breast...

Dr Johannes Coy Q+A

Dr Johannes Coy Q+A

[row style="large"] [col span="8" span__sm="12" align="center"] [ux_image id="622" image_size="2048x2048"] [ux_image id="623"] [/col] [col span="1"...

Growing Cancer Diagnoses in the Middle East

Growing Cancer Diagnoses in the Middle East

This week we were shocked by news of a new study in the Middle East.  This study has found that young people across the UAE and Saudi Arabia are four times more likely to be diagnosed with cancer than their counterparts in the U.K and United States. We know that...

Liquid Biopsy: The Future of Cancer Diagnostics

Liquid Biopsy: The Future of Cancer Diagnostics

The gold standard in cancer detection has always been tissue biopsy. But the procedure is invasive, time-consuming, and often painful or stressful for patients. More significantly, its efficacy is often limited: cancer cells may not be present in biopsied areas, and...

PanTum Detect: The solution to the COVID effect on Cancer?

PanTum Detect: The solution to the COVID effect on Cancer?

‘The knock-on impact of the pandemic on cancer care cannot be overstated’. These are the words of Steven McIntosh, the executive director of advocacy and communications at Macmillan Cancer Support, reported in a shocking article in The Guardian last week. There’s no...

Categories